首页 > 最新文献

Indian Journal of Critical Care Medicine最新文献

英文 中文
Risk Factors for Mortality after Out-of-hospital Resuscitation are More Diverse than Assumed.
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 Epub Date: 2024-12-30 DOI: 10.5005/jp-journals-10071-24872
Josef Finsterer, Carla A Scorza, Fulvio A Scorza, Ana C Fiorini

How to cite this article: Finsterer J, Scorza CA, Scorza FA, Fiorini AC. Risk Factors for Mortality after Out-of-hospital Resuscitation are More Diverse than Assumed. Indian J Crit Care Med 2025;29(1):92-93.

{"title":"Risk Factors for Mortality after Out-of-hospital Resuscitation are More Diverse than Assumed.","authors":"Josef Finsterer, Carla A Scorza, Fulvio A Scorza, Ana C Fiorini","doi":"10.5005/jp-journals-10071-24872","DOIUrl":"10.5005/jp-journals-10071-24872","url":null,"abstract":"<p><p><b>How to cite this article:</b> Finsterer J, Scorza CA, Scorza FA, Fiorini AC. Risk Factors for Mortality after Out-of-hospital Resuscitation are More Diverse than Assumed. Indian J Crit Care Med 2025;29(1):92-93.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 1","pages":"92-93"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Efficacy and Safety of Ibutilide in Cardioversion of Atrial Fibrillation or Flutter in Indian Patients: A Multicenter Study.
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 Epub Date: 2024-12-30 DOI: 10.5005/jp-journals-10071-24885
Bhupesh Dewan, Sanjaykumar Navale, Siddheshwar Shinde, Janaki Chaudhary

Aim and background: To assess the efficacy and safety of Ibutilide infusion for cardioversion of atrial fibrillation (AF) or flutter (AFL) to sinus rhythm.

Materials and methods: This open-label, multicenter phase IV study was conducted at six sites across India. The study enrolled 120 patients (108 with AF, 12 with AFL), each receiving up to two, 10-minute intravenous doses of 1.0 mg Ibutilide. The primary endpoints were the proportion of patients achieving cardioversion and the mean time taken to achieve cardioversion. Secondary endpoints included the proportion of patients maintaining sinus rhythm at 24 hours and the incidence of adverse events.

Results: The cardioversion rate at 4 hours post-Ibutilide infusion among 120 patients was 65.83% (n = 79), with an average conversion time of 35.12 ± 36.71 minutes. At 24 hours, 85 patients (70.8%) had successful cardioversion, with a mean time of 107.24 minutes. The majority of patients (71.76%) had achieved cardioversion within 30 minutes. Of the 85 patients who achieved successful conversion, 82 (68.3%) maintained sinus rhythm at 24 hours. A total of 66 patients (55%) achieved cardioversion with the first bolus whereas 19 (15.8%) needed a second bolus. Atrial fibrillation patients had a higher conversion rate (75%) compared to AFL patients (33%). A total of 10 adverse events were recorded in eight patients (6.67%), including nausea, headache, palpitations, and bradycardia. Three severe cardiac events, one case of ventricular tachycardia, and two of tachycardia necessitated discontinuation of Ibutilide. No fatalities or serious adverse events (SAE) were reported.

Conclusion: Ibutilide was found to be effective and well-tolerated for rapid restoration of sinus rhythm in patients with AF or AFL.

Clinical trial registry of india: CTRI/2018/01/011248.

How to cite this article: Dewan B, Navale S, Shinde S, Chaudhary J. Clinical Efficacy and Safety of Ibutilide in Cardioversion of Atrial Fibrillation or Flutter in Indian Patients: A Multicenter Study. Indian J Crit Care Med 2025;29(1):45-51.

{"title":"Clinical Efficacy and Safety of Ibutilide in Cardioversion of Atrial Fibrillation or Flutter in Indian Patients: A Multicenter Study.","authors":"Bhupesh Dewan, Sanjaykumar Navale, Siddheshwar Shinde, Janaki Chaudhary","doi":"10.5005/jp-journals-10071-24885","DOIUrl":"10.5005/jp-journals-10071-24885","url":null,"abstract":"<p><strong>Aim and background: </strong>To assess the efficacy and safety of Ibutilide infusion for cardioversion of atrial fibrillation (AF) or flutter (AFL) to sinus rhythm.</p><p><strong>Materials and methods: </strong>This open-label, multicenter phase IV study was conducted at six sites across India. The study enrolled 120 patients (108 with AF, 12 with AFL), each receiving up to two, 10-minute intravenous doses of 1.0 mg Ibutilide. The primary endpoints were the proportion of patients achieving cardioversion and the mean time taken to achieve cardioversion. Secondary endpoints included the proportion of patients maintaining sinus rhythm at 24 hours and the incidence of adverse events.</p><p><strong>Results: </strong>The cardioversion rate at 4 hours post-Ibutilide infusion among 120 patients was 65.83% (<i>n</i> = 79), with an average conversion time of 35.12 ± 36.71 minutes. At 24 hours, 85 patients (70.8%) had successful cardioversion, with a mean time of 107.24 minutes. The majority of patients (71.76%) had achieved cardioversion within 30 minutes. Of the 85 patients who achieved successful conversion, 82 (68.3%) maintained sinus rhythm at 24 hours. A total of 66 patients (55%) achieved cardioversion with the first bolus whereas 19 (15.8%) needed a second bolus. Atrial fibrillation patients had a higher conversion rate (75%) compared to AFL patients (33%). A total of 10 adverse events were recorded in eight patients (6.67%), including nausea, headache, palpitations, and bradycardia. Three severe cardiac events, one case of ventricular tachycardia, and two of tachycardia necessitated discontinuation of Ibutilide. No fatalities or serious adverse events (SAE) were reported.</p><p><strong>Conclusion: </strong>Ibutilide was found to be effective and well-tolerated for rapid restoration of sinus rhythm in patients with AF or AFL.</p><p><strong>Clinical trial registry of india: </strong>CTRI/2018/01/011248.</p><p><strong>How to cite this article: </strong>Dewan B, Navale S, Shinde S, Chaudhary J. Clinical Efficacy and Safety of Ibutilide in Cardioversion of Atrial Fibrillation or Flutter in Indian Patients: A Multicenter Study. Indian J Crit Care Med 2025;29(1):45-51.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 1","pages":"45-51"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Response: Risk Factors for Mortality after Out-of-hospital Resuscitation are More Diverse than Assumed.
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 Epub Date: 2024-12-30 DOI: 10.5005/jp-journals-10071-24878
Darpanarayan Hazra, Amal Al-Mandhari

How to cite this article: Hazra D, Al-Mandhari A. Author Response: Risk Factors for Mortality after Out-of-hospital Resuscitation are More Diverse than Assumed. Indian J Crit Care Med 2025;29(1):94.

{"title":"Author Response: Risk Factors for Mortality after Out-of-hospital Resuscitation are More Diverse than Assumed.","authors":"Darpanarayan Hazra, Amal Al-Mandhari","doi":"10.5005/jp-journals-10071-24878","DOIUrl":"https://doi.org/10.5005/jp-journals-10071-24878","url":null,"abstract":"<p><p><b>How to cite this article:</b> Hazra D, Al-Mandhari A. Author Response: Risk Factors for Mortality after Out-of-hospital Resuscitation are More Diverse than Assumed. Indian J Crit Care Med 2025;29(1):94.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 1","pages":"94"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719551/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Point-of-care Ultrasound of Airway to Predict Difficult Laryngoscopy and Intubation in Intensive Care Unit Patients.
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 Epub Date: 2024-12-30 DOI: 10.5005/jp-journals-10071-24871
Shreyasi Mallick, Saswati Das, Sujit Pradhan, Supriya Kar

Background: To evaluate the role of ultrasound (US) in the assessment of the airway and to determine whether US has the potential to serve as effective, noninvasive and less time-consuming method for the diagnosis of difficult intubation in ICU patients.

Patients and methods: This cross-sectional study was carried in 152 critically ill patients who underwent intubation in the ICU from December 2022 to April 2024. Prior to intubation thyromental height (TMH) and hyomental distance ratio (HMD-R) was measured using a scale and distance from skin to hyoid bone (SHB) and distance from skin to thyrohyoid membrane (STM) was measured using a US. Direct laryngoscopy was performed using a Macintosh blade, and the Cormack-Lehane (CL) grade was noted without external laryngeal manipulation. The laryngoscopy was classified as easy (CL Grade I and II) or difficult (CL Grade III and IV). The number of attempts at intubation, need for alternative difficult intubation approaches or inability to secure the airway was also noted.

Results: The incidence of difficult airway was 17.76%. The success rate for first-attempt intubation was 96.7%. Based on the receiver operating characteristic (ROC) curve analysis cut-off value of 1.97 cm [95% confidence interval (CI), 0.949-0.996, area under the curve (AUC), 0.972] for anterior soft tissue thickness from the skin to thyrohyoid membrane distinguished the difficult intubation group from the easy intubation group, with a sensitivity of 96.3% and specificity of 86.4%. For the hyoid bone level, a cut-off value of 0.905 cm (95% CI, 0.706-0.887, AUC, 0.797) had a sensitivity of 74.1% and specificity of 74.4%. Anterior soft tissue thickness from the skin to thyrohyoid membrane was a better predictor of a difficult airway. There was a significant correlation between clinical airway assessments and US airway assessments.

Conclusion: Point-of-care US can serve as an independent tool for assessing the airway in intensive care unit (ICU) patients, with anterior soft tissue thickness from skin to thyrohyoid membrane being a superior predictor. Combined models of sonographic and clinical tests could enhance the diagnostic value for identifying difficult intubation cases in ICU patients.

How to cite this article: Mallick S, Das S, Pradhan S, Kar S. Evaluation of Point-of-care Ultrasound of Airway to Predict Difficult Laryngoscopy and Intubation in Intensive Care Unit Patients. Indian J Crit Care Med 2025;29(1):14-20.

{"title":"Evaluation of Point-of-care Ultrasound of Airway to Predict Difficult Laryngoscopy and Intubation in Intensive Care Unit Patients.","authors":"Shreyasi Mallick, Saswati Das, Sujit Pradhan, Supriya Kar","doi":"10.5005/jp-journals-10071-24871","DOIUrl":"10.5005/jp-journals-10071-24871","url":null,"abstract":"<p><strong>Background: </strong>To evaluate the role of ultrasound (US) in the assessment of the airway and to determine whether US has the potential to serve as effective, noninvasive and less time-consuming method for the diagnosis of difficult intubation in ICU patients.</p><p><strong>Patients and methods: </strong>This cross-sectional study was carried in 152 critically ill patients who underwent intubation in the ICU from December 2022 to April 2024. Prior to intubation thyromental height (TMH) and hyomental distance ratio (HMD-R) was measured using a scale and distance from skin to hyoid bone (SHB) and distance from skin to thyrohyoid membrane (STM) was measured using a US. Direct laryngoscopy was performed using a Macintosh blade, and the Cormack-Lehane (CL) grade was noted without external laryngeal manipulation. The laryngoscopy was classified as easy (CL Grade I and II) or difficult (CL Grade III and IV). The number of attempts at intubation, need for alternative difficult intubation approaches or inability to secure the airway was also noted.</p><p><strong>Results: </strong>The incidence of difficult airway was 17.76%. The success rate for first-attempt intubation was 96.7%. Based on the receiver operating characteristic (ROC) curve analysis cut-off value of 1.97 cm [95% confidence interval (CI), 0.949-0.996, area under the curve (AUC), 0.972] for anterior soft tissue thickness from the skin to thyrohyoid membrane distinguished the difficult intubation group from the easy intubation group, with a sensitivity of 96.3% and specificity of 86.4%. For the hyoid bone level, a cut-off value of 0.905 cm (95% CI, 0.706-0.887, AUC, 0.797) had a sensitivity of 74.1% and specificity of 74.4%. Anterior soft tissue thickness from the skin to thyrohyoid membrane was a better predictor of a difficult airway. There was a significant correlation between clinical airway assessments and US airway assessments.</p><p><strong>Conclusion: </strong>Point-of-care US can serve as an independent tool for assessing the airway in intensive care unit (ICU) patients, with anterior soft tissue thickness from skin to thyrohyoid membrane being a superior predictor. Combined models of sonographic and clinical tests could enhance the diagnostic value for identifying difficult intubation cases in ICU patients.</p><p><strong>How to cite this article: </strong>Mallick S, Das S, Pradhan S, Kar S. Evaluation of Point-of-care Ultrasound of Airway to Predict Difficult Laryngoscopy and Intubation in Intensive Care Unit Patients. Indian J Crit Care Med 2025;29(1):14-20.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 1","pages":"14-20"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719556/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intravenous Fluid Prescription in Diabetic Ketoacidosis: Where is the Evidence?
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 Epub Date: 2024-12-30 DOI: 10.5005/jp-journals-10071-24875
Supradip Ghosh

How to cite this article Ghosh S. Intravenous Fluid Prescription in Diabetic Ketoacidosis: Where is the Evidence? Indian J Crit Care Med 2025;29(1):10-11.

如何引用本文 Ghosh S. 《糖尿病酮症酸中毒的静脉输液处方》:证据何在?Indian J Crit Care Med 2025;29(1):10-11.
{"title":"Intravenous Fluid Prescription in Diabetic Ketoacidosis: Where is the Evidence?","authors":"Supradip Ghosh","doi":"10.5005/jp-journals-10071-24875","DOIUrl":"10.5005/jp-journals-10071-24875","url":null,"abstract":"<p><p><b>How to cite this article</b> Ghosh S. Intravenous Fluid Prescription in Diabetic Ketoacidosis: Where is the Evidence? Indian J Crit Care Med 2025;29(1):10-11.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 1","pages":"10-11"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nurse-led Enhanced Recovery after Surgery Programs: Potential Solution to Shorten Postoperative Recovery.
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 Epub Date: 2024-12-30 DOI: 10.5005/jp-journals-10071-24883
Niraj Tyagi

How to cite this article: Tyagi N. Nurse-led Enhanced Recovery after Surgery Programs: Potential Solution to Shorten Postoperative Recovery. Indian J Crit Care Med 2025;29(1):3-5.

{"title":"Nurse-led Enhanced Recovery after Surgery Programs: Potential Solution to Shorten Postoperative Recovery.","authors":"Niraj Tyagi","doi":"10.5005/jp-journals-10071-24883","DOIUrl":"10.5005/jp-journals-10071-24883","url":null,"abstract":"<p><p><b>How to cite this article:</b> Tyagi N. Nurse-led Enhanced Recovery after Surgery Programs: Potential Solution to Shorten Postoperative Recovery. Indian J Crit Care Med 2025;29(1):3-5.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 1","pages":"3-5"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Response: Insights into Immunomodulatory Therapy for Sepsis.
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 Epub Date: 2024-12-30 DOI: 10.5005/jp-journals-10071-24874
Indranil Ghosh, Sukhwinder S Sangha, Gaurav Pandey, Atul Srivastava

How to cite this article: Ghosh I, Sangha SS, Pandey G, Srivastava A. Author Response: Insights into Immunomodulatory Therapy for Sepsis. Indian J Crit Care Med 2025;29(1):91.

如何引用本文:Ghosh I, Sangha SS, Pandey G, Srivastava A. Author Response:对败血症免疫调节疗法的见解。Indian J Crit Care Med 2025;29(1):91.
{"title":"Author Response: Insights into Immunomodulatory Therapy for Sepsis.","authors":"Indranil Ghosh, Sukhwinder S Sangha, Gaurav Pandey, Atul Srivastava","doi":"10.5005/jp-journals-10071-24874","DOIUrl":"10.5005/jp-journals-10071-24874","url":null,"abstract":"<p><p><b>How to cite this article:</b> Ghosh I, Sangha SS, Pandey G, Srivastava A. Author Response: Insights into Immunomodulatory Therapy for Sepsis. Indian J Crit Care Med 2025;29(1):91.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 1","pages":"91"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Predispositions, Features, and Outcomes of Infections with Carbapenem-resistant Enterobacterales among Critical Care Patients.
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 Epub Date: 2024-12-30 DOI: 10.5005/jp-journals-10071-24876
Ahmed R El-Karamany Shoala, Yasser Nassar, Amani A El-Kholy, Noha S Soliman, Alia Abdel-Fattah, Helmy El-Ghawaby

Background: Carbapenem-resistant Enterobacterales (CRE) infections pose a significant global public health threat. We aimed to assess the risk variables, clinical characteristics, and outcomes of CRE-caused infections in criticalcare patients.

Patients and methods: This prospective study enrolled 181 adult patients infected with Enterobacterales in the intensive care unit (ICU). Patients underwent clinical assessment and monitoring throughout their ICU stay. Carbapenem resistance was identified through antibiotic susceptibility testing and multiplex molecular detection of carbapenemase-encoding genes.

Results: The mean age of patients was 67.99 ± 12.89 years, with 71.3% being males. Of 181 patients, 111 (61.3%) were found to have CRE infections, including 39 Klebsiella pneumoniae and 31 Escherichia coli isolates. The CRE isolates showed the predominance of the OXA-48 (74.8%), followed by the NewDelhi Metallobetalactamase (NDM) carbapenemase genes (20.7%). The risk factors associated with CRE infection included high sequential organ failure assessment (SOFA) score, prolonged length of stay (LOS) in ICU, prior use of broad-spectrum antimicrobials, hemodialysis, plasma exchange, and prolonged mechanical ventilation. Carbapenem-resistant Enterobacterales infections significantly required longer LOS, more need for mechanical ventilation, and exhibited lower rates of bacterial elimination than carbapenem-susceptible Enterobacterales (CSE) infections. The type of resistance gene did not significantly influence the mortality rate among CRE patients. The successful treatment of OXA-48-positive CRE showed a strong correlation with tigecycline and colistin antibiotics.

Conclusion: Carbapenem-resistant Enterobacterales infection in ICU patients was associated with adverse outcomes. Identification of high-risk patients is essential for early diagnosis and appropriate management. Therefore, it is crucial to improve infection control methods and implement antimicrobial stewardship to avoid spreading infections.

How to cite this article: Shoala ARK, Nassar Y, El-Kholy AA, Soliman NS, Abdel-Fattah A, El-Ghawaby H. Clinical Predispositions, Features, and Outcomes of Infections with Carbapenem-resistant Enterobacterales among Critical Care Patients. Indian J Crit Care Med 2025;29(1):36-44.

背景:耐碳青霉烯类肠杆菌(CRE)感染对全球公共卫生构成重大威胁。我们旨在评估重症监护患者中由 CRE 引起的感染的风险变量、临床特征和结果:这项前瞻性研究纳入了重症监护病房(ICU)中感染肠杆菌的 181 名成人患者。患者在重症监护室住院期间一直接受临床评估和监测。通过抗生素药敏试验和碳青霉烯酶编码基因的多重分子检测确定碳青霉烯耐药性:患者的平均年龄为(67.99±12.89)岁,71.3%为男性。在 181 名患者中,发现 111 人(61.3%)感染了 CRE,其中包括 39 个肺炎克雷伯菌和 31 个大肠埃希菌分离株。分离出的 CRE 主要含有 OXA-48 基因(74.8%),其次是 NewDelhi Metallobetalactamase(NDM)碳青霉烯酶基因(20.7%)。与CRE感染相关的风险因素包括:器官功能衰竭序列评估(SOFA)评分高、在重症监护室的住院时间(LOS)长、曾使用广谱抗菌药物、血液透析、血浆置换和长时间机械通气。与碳青霉烯类易感肠杆菌属(CSE)感染相比,耐碳青霉烯类肠杆菌属感染明显需要更长的住院时间、更多的机械通气需求以及更低的细菌清除率。耐药基因的类型对 CRE 患者的死亡率没有明显影响。OXA-48 阳性 CRE 的成功治疗与替加环素和可乐定抗生素密切相关:结论:ICU 患者中耐碳青霉烯类肠杆菌感染与不良预后有关。识别高危患者对于早期诊断和适当治疗至关重要。因此,改进感染控制方法和实施抗菌药物管理以避免感染扩散至关重要:Shoala ARK, Nassar Y, El-Kholy AA, Soliman NS, Abdel-Fattah A, El-Ghawaby H. 重症监护患者耐碳青霉烯类肠杆菌感染的临床倾向、特征和结果。Indian J Crit Care Med 2025;29(1):36-44.
{"title":"Clinical Predispositions, Features, and Outcomes of Infections with Carbapenem-resistant <i>Enterobacterales</i> among Critical Care Patients.","authors":"Ahmed R El-Karamany Shoala, Yasser Nassar, Amani A El-Kholy, Noha S Soliman, Alia Abdel-Fattah, Helmy El-Ghawaby","doi":"10.5005/jp-journals-10071-24876","DOIUrl":"10.5005/jp-journals-10071-24876","url":null,"abstract":"<p><strong>Background: </strong>Carbapenem-resistant <i>Enterobacterales</i> (CRE) infections pose a significant global public health threat. We aimed to assess the risk variables, clinical characteristics, and outcomes of CRE-caused infections in criticalcare patients.</p><p><strong>Patients and methods: </strong>This prospective study enrolled 181 adult patients infected with <i>Enterobacterales</i> in the intensive care unit (ICU). Patients underwent clinical assessment and monitoring throughout their ICU stay. Carbapenem resistance was identified through antibiotic susceptibility testing and multiplex molecular detection of carbapenemase-encoding genes.</p><p><strong>Results: </strong>The mean age of patients was 67.99 ± 12.89 years, with 71.3% being males. Of 181 patients, 111 (61.3%) were found to have CRE infections, including 39 <i>Klebsiella pneumoniae</i> and 31 <i>Escherichia</i> <i>coli</i> isolates. The CRE isolates showed the predominance of the <i>OXA-48</i> (74.8%), followed by the <i>NewDelhi Metallobetalactamase (NDM) carbapenemase</i> genes (20.7%). The risk factors associated with CRE infection included high sequential organ failure assessment (SOFA) score, prolonged length of stay (LOS) in ICU, prior use of broad-spectrum antimicrobials, hemodialysis, plasma exchange, and prolonged mechanical ventilation. Carbapenem-resistant <i>Enterobacterales</i> infections significantly required longer LOS, more need for mechanical ventilation, and exhibited lower rates of bacterial elimination than carbapenem-susceptible <i>Enterobacterales</i> (CSE) infections. The type of resistance gene did not significantly influence the mortality rate among CRE patients. The successful treatment of <i>OXA-48</i>-positive CRE showed a strong correlation with tigecycline and colistin antibiotics.</p><p><strong>Conclusion: </strong>Carbapenem-resistant <i>Enterobacterales</i> infection in ICU patients was associated with adverse outcomes. Identification of high-risk patients is essential for early diagnosis and appropriate management. Therefore, it is crucial to improve infection control methods and implement antimicrobial stewardship to avoid spreading infections.</p><p><strong>How to cite this article: </strong>Shoala ARK, Nassar Y, El-Kholy AA, Soliman NS, Abdel-Fattah A, El-Ghawaby H. Clinical Predispositions, Features, and Outcomes of Infections with Carbapenem-resistant <i>Enterobacterales</i> among Critical Care Patients. Indian J Crit Care Med 2025;29(1):36-44.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 1","pages":"36-44"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous Infusion of Propofol or Dexmedetomidine should not be the First Choice to Prevent Postoperative Delirium after Hip Fracture.
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 Epub Date: 2024-12-30 DOI: 10.5005/jp-journals-10071-24864
Josef Finsterer, João G Marques

How to cite this article: Finsterer J, Marques JG. Continuous Infusion of Propofol or Dexmedetomidine should not be the First Choice to Prevent Postoperative Delirium after Hip Fracture. Indian J Crit Care Med 2025;29(1):86-87.

{"title":"Continuous Infusion of Propofol or Dexmedetomidine should not be the First Choice to Prevent Postoperative Delirium after Hip Fracture.","authors":"Josef Finsterer, João G Marques","doi":"10.5005/jp-journals-10071-24864","DOIUrl":"10.5005/jp-journals-10071-24864","url":null,"abstract":"<p><p><b>How to cite this article:</b> Finsterer J, Marques JG. Continuous Infusion of Propofol or Dexmedetomidine should not be the First Choice to Prevent Postoperative Delirium after Hip Fracture. Indian J Crit Care Med 2025;29(1):86-87.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 1","pages":"86-87"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Response: Continuous Infusion of Propofol or Dexmedetomidine should not be the First Choice to Prevent Postoperative Delirium in Patients after Hip Fracture.
IF 1.5 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 Epub Date: 2024-12-30 DOI: 10.5005/jp-journals-10071-24869
Gamonmas Ekkapat, Nalin Chokengarmwong

How to cite this article: Ekkapat G, Chokengarmwong N. Author Response: Continuous Infusion of Propofol or Dexmedetomidine should not be the First Choice to Prevent Postoperative Delirium in Patients after Hip Fracture. Indian J Crit Care Med 2025;29(1):88-89.

{"title":"Author Response: Continuous Infusion of Propofol or Dexmedetomidine should not be the First Choice to Prevent Postoperative Delirium in Patients after Hip Fracture.","authors":"Gamonmas Ekkapat, Nalin Chokengarmwong","doi":"10.5005/jp-journals-10071-24869","DOIUrl":"10.5005/jp-journals-10071-24869","url":null,"abstract":"<p><p><b>How to cite this article:</b> Ekkapat G, Chokengarmwong N. Author Response: Continuous Infusion of Propofol or Dexmedetomidine should not be the First Choice to Prevent Postoperative Delirium in Patients after Hip Fracture. Indian J Crit Care Med 2025;29(1):88-89.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"29 1","pages":"88-89"},"PeriodicalIF":1.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1